Pentamaster’s growing medical segment to continue revenue rise

CGS-CIMB Research revised its FY23 to FY25 earnings forecast for Pentamaster by 4.4% to 9.6%.

PETALING JAYA: Analysts expect Pentamaster Corp Bhd to experience a slowdown in its automotive segment due to competition from electric vehicles (EVs) that is likely to have an impact on the group moving forward.

CGS-CIMB Research said Pentamaster’s growing medical segment is expected to help cushion any near-term moderation in the group’s automotive segment.